Which patients with myelofibrosis should receive ruxolitinib therapy?: ELN-SIE evidence-based recommendations
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Leukemia
Year: 2017, Volume: 31, Issue: 4, Pages: 882-888 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/leu.2016.283 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1038/leu.2016.283 Verlag, Volltext: http://www.nature.com/doifinder/10.1038/leu.2016.283 
|
| Author Notes: | M. Marchetti, G. Barosi, F. Cervantes, G. Birgegård, M. Griesshammer, C. Harrison, R. Hehlmann, J.-J. Kiladjian, N. Kröger, M.F. McMullin, F. Passamonti, A. Vannucchi and T. Barbui |
| Item Description: | Published 14 October 2016 Gesehen am01.10.2018 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/leu.2016.283 |